iStock-1079939122_ajustes (5).jpg

Almirall News Centre

Header

Latest news

16 March 2026

Lebrikizumab delivered significant skin clearance and improved disease severity in children with moderate-to-severe atopic dermatitis

12 March 2026

Almirall inaugurates offices in China to advance innovation in medical dermatology through partnerships

23 February 2026

Almirall meets guidance for 2025, delivering 12.4% net sales growth and further pipeline progress, continuing its sustained growth trajectory with strong dermatology performance and commercial execution in Europe

Useful information

About us

Everything you need to know about Almirall.

Atopic dermatitis press kit

Information about the disease and our latest biologic treatment.

Multimedia

Our brand in pictures and videos.

Go to multimedia

Media contact

Almirall Media Relations

Corporate Communications

corporate.communication@almirall.com

T +34 932 91 35 08